What is OUTLOOK THERAPEUTICS INC?
, operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic bevacizumab product formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 100.54M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.